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mAs each of the authors in this supplement has noted, the
relationships between physicians and industry offer at once
the opportunity to generate great advances in medical
therapies and the potential for abuse and inappropriate
influence on physician behavior. For a variety of reasons,
awareness of the potentially negative impact of these rela-
tionships has recently been heightened, particularly in
device-intensive specialties, in contrast to past emphasis on
the advances of medical science that have been realized as a
result of physician–industry collaboration.
The recent focus on conflict of interest in relationships
between physicians and industry results from both real and
perceived abuses of this relationship in the past and has
come from a number of sectors, as will be outlined in the
following articles. These include federal and state legislative
bodies, the Veterans Health Administration, academic
medical centers, professional medical associations, pharma-
ceutical and device manufacturers, and physicians.
Although all can agree in principal that the optimal
approach to managing these relationships supports the
constructive collaboration between these two sectors while
minimizing impropriety, intense debate continues around
exactly what the specific limits of these relationships should
be. The articles contained within this supplement articulate
the wide range of opinions and perspectives relevant to this
debate, using as a framework the presentations by partici-
pants at the Crawford Critical Issues Forum at the 2010
Vascular Annual Meeting and augmented by additional
contributions from experts in related areas.
Analysis of the issues facing professional medical asso-
ciations is provided by Dr Michael Dalsing, who examines
the complex relationships between our representative soci-
eties and industry. Although virtually all are dependent on
industry support to maintain their operations and activities,
they are simultaneously held to a higher standard of behav-
ior because they are the public face of our profession.
The Society for Vascular Surgery policies and proce-
dures around conflict of interest issues, including the new
societal guidelines and the newly formed Conflict of Inter-
est Committee, are described by Dr Bruce Elliott, who
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doi:10.1016/j.jvs.2011.04.064hairs the committee. The background behind the devel-
pment of the new Society for Vascular Surgery Conflict of
nterest Guidelines and an exploration of the issues driving
he conflict of interest movement are provided by Dr
ynthia K. Shortell, who participated in the creation of the
ew guidelines.
Dr Jack Lewin provides the perspective of the American
ollege of Cardiology onmaintaining appropriate relation-
hips with industry, which includes education of the public
egarding how industry and physicians can interact properly
o develop new therapies for patients.
The Council of Medical Specialty Societies has devel-
ped a code designed to help professional medical associa-
ions and individual practitioners properly manage their
elationships with industry in a way that minimizes con-
icts. This code and an analysis of the related issues are
rovided by Drs Kahn and Lichter.
Medical publishers and editors, like professional medi-
al societies, are held to a very high standard of behavior
ecause failure to control conflict of interest in this setting
hreatens the very fabric of our profession—the discovery
nd dissemination of scientific knowledge. An outline of
he issues faced and the optimal approach to conflict of
nterest in medical publishing and editing is provided by Dr
apan Desai. The Director of the Department of Surgery at
ohns Hopkins Medical Institutions, Dr Julie Ann Freis-
hlag, outlines the responses to conflict of interest chal-
enges faced by academic medical centers, many of whom
ave written very strict guidelines governing physician–
ndustry interactions.
The Veterans Health Administration has been an early
eader in managing conflict of interest for its physicians and
acilities, and the relatively rigorous guidelines and conse-
uences for their violation are discussed by Drs Tyler and
anna.
Industry, and specifically, the Advanced Medical Tech-
ology Association (AdvaMed) and the Pharmaceutical
esearch and Manufacturers of America (PhRMA), repre-
enting the device and pharmaceutical sectors, respectively,
ave been proactive in addressing the conflict of interest
ssue early and independently. Each has created its own set
f voluntary guidelines and encouraged participation by all
endors. The AdvaMed Code is presented and the perspec-
ive of industry outlined by Andrew Van Haute.
The detrimental effects of current regulation governing
hysician–industry relations are discussed by Dr Cary Kim-
elstein. These include a negative economic impact in
ffected areas, along with reductions in continuing medical
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September Supplement 20112S Shortelleducation events, in innovation and new device training,
and in educational and training activities. On a related note,
Dr Russell Samson elaborates additional positive results of
physician–industry interactions, challenges the evidence
that interactions with industry inappropriately influence
physician behavior, and explores the different issues and
perspectives of the private practice physician compared with
the physician in an academic medical practice.
Even though we are vulnerable to fines and imprison-
ment for violation of certain federal and state regulations,
most of us are uneducated regarding the specifics of these
laws. Lawrence Conn and Lawrence Vernaglia, attorneys at
Foley and Lardner, LLP, detail the content of all the
legislation relevant to physician–industry relations as well as
the consequences for violation.
Although the reader may believe that conflict of inter-
est issues are not relevant to his or her daily life as a
physician, nothing could be further from the truth; in fact,
conflict of interest issues now pervade virtually every aspect
of our life. New regulations are being imposed continually
in the form of legislation, institutional standards, profes-
sional mandates, and industry guidelines, and these regula-
tions are changing the routines that have characterized our
existence as physicians for decades. Examples of once ac-
ceptable activities that are currently under scrutiny or
banned include the receipt of personal gifts of any kind,
directed educational grants for trainees, support for new Device training, funding of professional societal activities,
rovision of on-site and off-site meals, participation in
peakers’ bureaus, and vendor visits to hospitals and clinics,
ncluding participation in operative procedures. The degree
o which these actions are prohibited or regulated depends
n the provider, the vendor, and the institution. Further-
ore, the variability in regulation across these entities leads
o confusion and inequities among providers; a minor but
mblematic example of this was the prohibition against
ood consumption within the exhibit hall by practitioners
icensed in the states of Massachusetts, Minnesota, and
ermont at our 2010 Annual Meeting held in Boston,
assachusetts.
Clearly, there is a need for a cohesive and overarching
et of guidelines applicable to all practitioners and vendors.
owever, creation of such a set of guidelines will need to
ake into consideration all the issues and perspectives of the
ifferent stakeholders as outlined in this supplement—a
hallenging prospect at minimum. As physicians, we must
e the leaders of the effort to create such a set of guidelines,
or it is we who understand best both the invaluable bene-
ts that are realized from collaboration with industry, as
ell as areas where we are most vulnerable to misuse of the
elationship.
ynthia K. Shortell, MD
urham, NC
